Prediction of bladder cancer based on urinary content of MGEA5 and OGT mRNA level

Clinical Laboratory

Volumn 58, Issue 5-6, 2012, Pages 579-583

  Rozanski, Waldemar ^a   Krzeslak, Anna ^b   Forma, Ewa ^b   Brys, Magdalena ^b   Blewniewski, Mariusz ^a   Wozniak, Paweł ^a   Lipinski, Marek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

Bladder cancer; MGEA5; OGT; Urine markers

Indexed keywords

MENINGIOMA EXPRESSED ANTIGEN 5; MESSENGER RNA; OGT PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; URINALYSIS; URINE;

AGED; ANTIGENS, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HISTONE ACETYLTRANSFERASES; HUMANS; HYALURONOGLUCOSAMINIDASE; MALE; MIDDLE AGED; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84863642965     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hartmann A, Bertz S. Histopathology and Molecular Pathology of Bladder Cancer. In: Lokeshwar VB, Merseburger AS, Hautmann SH (eds). Bladder Tumors, Molecular Aspects and Clinical Management, 1st ed. Humana Press, 2011:43-61.
2. Luis NM, López-Knowles E, Real FX. Molecular biology of bladder cancer. Clin Transi Oncol 2007;9:5-12.
3. Mitra AP, Bartsch CC, Cote RJ. Strategies for molecular expression profiling in bladder cancer. Cancer Metastasis Rev 2009;28:317-26.
4. Butkinaree C, Park K, Hart GW. O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Biochim Biophys Acta 2010;1800:96-106.
5. Hanover JA, Krause MW, Love DC. The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine. Biochim Biophys Acta 2010;1800:80-95.
6. Zeidan Q, Hart GW. The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J Cell Science 2010;123:13-22.
7. O'Donnell N, Zachara NE, Hart GW, Marth JD. Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability. Mol Cell Biol 2004;24:1680-90. (Pubitemid 38167089)
8. Heckel D, Comtesse N, Brass N, Blin N, Zang KD, Meese E. Novel immunogenic antigen homologous to hyaluronidase in meningioma. Hum Mol Genet 1998;7:1859-72. (Pubitemid 28499417)
9. Lazarus BD, Love DC, Hanover JA. O-GlcNAc cycling: implications for neurodegenerative disorders. Int J Biochem Cell Biol 2009;41:2134-46.
10. Krzeslak A, Pomorski L, Lipinska A. Elevation of nucleocyto-plasmic beta-N-acetylglucosaminidase (O-GlcNAcase) activity in thyroid cancers. Int J Mol Med 2010;25:643-8.
11. Slawson C, Pidala I, Potter R. Increased N-acetyl-beta-glucosaminidase activity in primary breast carcinomas corresponds to a decrease in N-acetylglucosamine containing proteins. Biochim Biophys Acta 2001;1537:147-57. (Pubitemid 32885616)
12. Mi W, Gu Y, Han C, et al. O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy. Biochim Biophys Acta 2011;1812:514-9.
13. Slawson C, Copeland RJ, Hart GW. O-GlcNAc signaling: a metabolic link between diabetes and cancer? Trends Biochem Sci 2010;35:547-55.
14. Özcan S, Andrali SS, Cantrell JEL. Modulation of transcription factor function by O-GlcNAc modification. Biochim Biophys Acta 2010;1799:353-64.
15. Slawson C, Zachara NE, Vosseller K, Cheung WD, Lane MD, Hart GW. Perturbations in O-linked-beta-N-acetylglucosamine protein modification causes in severe defects in mitotic progresssion and cytokinesis. J Biol Chem 2005;280:32944-56. (Pubitemid 41368344)
16. Caldwell SA, Jackson SR, Shahriari KS, et al. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene 2010;29:2831-42.
17. Krześlak A, Forma E, Bernaciak M, Romanowicz H, Bryś M. Gene expression of O-GlcNAc cycling enzymes in human breast cancers. Clin Exp Med 2011;doi:10.1007/s10238-011-0138-5.
18. Chung S, Kang DO, Yamzon J, Warburton D, Koh CJ. O-Glc NAc mediated glycosylation down-regulation in mice with cyclophosphamide induced cystitis. J Urol 2010;183:351-6.
19. Hirao Y, Kim WJ, Fujimoto K. Environmental factors promoting bladder cancer. Curr Opin Urol 2009;19:494-9.